This trial is based on robust preclinical data and the recent results from CoVepiT 1, a human ex vivo study which resulted in the identification of immuno- …, This trial is based on robust preclinical data and the recent results from CoVepiT 1, a human ex vivo study which resulted in the identification of immuno- …, Read More